Medication info
Rosabel Tablets (Losartan Potassium)

Rosabel Tablets (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
PalmGen Science Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
300 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 200502026 · Notified 2005.03.28 · Insurance code 670100290

Summary

Main use
Treatment of hypertension and hypertensive nephropathy associated with type 2 diabetes
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Children and adolescents 6 years of age or older weighing 20 kg or more but less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age or older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
PalmGen Science Co., Ltd.

Efficacy & effects

Treatment of hypertension and hypertensive nephropathy associated with type 2 diabetes

  • Hypertension
  • kidney disease in type 2 diabetes patients
View approved original text

This medication is used to treat hypertension. It is especially effective in patients with type 2 diabetes who also develop kidney disease. It helps control blood pressure, thereby protecting cardiovascular and kidney function. Therefore, it is useful for the treatment of hypertension and related kidney complications.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time every day. Adults with hypertension: The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect occurs 3 ∼ 6 weeks after starting treatment. If the therapeutic effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, increased to 100 mg once daily. If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. Nephropathy in patients with type 2 diabetes and hypertension: The usual adult dose is 50 mg of this medicine once daily. The dose may be increased to 100 mg once daily depending on blood pressure. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used glucose-lowering agents (e.g., sulfonylureas, glitazones, and glucosidase inhibitors). No initial dose adjustment is necessary in elderly patients 75 years of age or younger. For patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. Creatinine clearance 20 ∼ 50 mL/min: No initial dose adjustment is necessary. Creatinine clearance < 20 mL/min and patients undergoing dialysis: An initial dose of 25 mg of this medicine once daily is recommended. For patients who may have reduced effective intravascular blood volume (e.g., patients receiving diuretic therapy), an initial dose of 25 mg of this medicine once daily is recommended (see Precautions for Use). Consider administering a lower dose to patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Children and adolescents 6 years of age or older weighing 20 kg or more but less than 50 kg who are able to swallow tablets: The recommended dose is 25 mg of this medicine once daily, which may be increased to a maximum of 50mg once daily depending on the patient's blood pressure response. Children and adolescents 6 years of age or older weighing 50 kg or more: The usual recommended dose is 50 mg of this medicine once daily, which may be increased to a maximum of 100 mg once daily depending on the patient's blood pressure response. Children under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should be discontinued immediately if pregnancy is confirmed. This medication should not be administered to patients with certain conditions, including those allergic to this drug or its components, pregnant women or women who may become pregnant, patients with severe liver impairment, patients with hereditary angioedema, and patients with primary hyperaldosteronism. Additionally, careful administration is required for certain patients, including the elderly, those with hyperkalemia, patients with liver impairment, patients with heart valve diseases, patients with decreased blood volume, and patients with severely reduced kidney function. Generally, this medication is well-tolerated; however, side effects such as muscle cramps, back pain, dizziness, and upper respiratory infections may occur, and rarely, serious side effects such as angioedema, liver function abnormalities, renal failure, or hypotension have been reported. Particular caution should be exercised when driving or operating machinery due to dizziness or orthostatic hypotension from blood pressure-lowering effects. This medication may interact with other drugs, so caution is advised when taken with potassium-sparing diuretics, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), lithium, etc., and consultation with a physician is necessary. Pregnant and breastfeeding women should avoid taking this medication, especially during pregnancy, due to potential risks to the fetus, and should consult a doctor to make a decision on whether to take it. In pediatric patients, it should not be administered to those under 6 years or with severely reduced kidney function. In cases of overdose, hypotension and bradycardia may occur, requiring immediate medical attention. During the course of treatment, regular monitoring of blood pressure, kidney function, and electrolyte levels is necessary, and consultation with a physician should occur if any abnormal symptoms arise. Finally, this medication should be stored out of the reach of children, and transferring it to another container should be avoided.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • low back pain
  • leg pain
  • dizziness
  • congestion
Show 130 more
  • upper respiratory tract infection
  • sinusitis
  • nausea
  • diarrhea
  • indigestion
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • bloating
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm desquamation
  • hemolysis
  • facial edema
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • appetite loss
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • arm pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • muscle stiffness
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory reduction
  • decreased libido
  • memory impairment
  • migraine
  • neural hyperreactivity
  • sensory abnormalities
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • narcolepsy
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • dry skin
  • purpura
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning sensation in the eyes
  • ocular pain
  • conjunctivitis
  • taste disorder
  • tinnitus
  • visual impairment
  • erectile dysfunction
  • nocturia
  • frequent urination
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • abnormal liver function
  • hepatitis
  • intestinal vascular edema
  • fatigue
  • thrombocytopenia
  • myalgia
  • weakness
  • elevated creatine kinase
  • rhabdomyolysis
  • taste disorder
  • dry cough
  • erythema multiforme
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beats
  • hypoglycemia
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is best stored at room temperature between 1 and 30 degrees Celsius.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

300 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.